Variant report

Variant	nsv883216
Chromosome Location	chr5:178002325-178025087
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:661)
CpG islands
(count:1710)
Chromatin interactive
region (count:16)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:661 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr5:178016908-178018114	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr5:178016327-178016499	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr5:178003565-178003761	H1-hESC	embryonic stem cell:	n/a	n/a
4	BCL11A	chr5:178012458-178012770	GM12878	blood:	n/a	n/a
5	BHLHE40	chr5:178013403-178013420	K562	blood:	n/a	n/a
6	BHLHE40	chr5:178012519-178012877	K562	blood:	n/a	n/a
7	BHLHE40	chr5:178007428-178007484	K562	blood:	n/a	n/a
8	BHLHE40	chr5:178017213-178017413	K562	blood:	n/a	n/a
9	BHLHE40	chr5:178017646-178018069	K562	blood:	n/a	n/a
10	BRCA1	chr5:178012520-178012716	GM12878	blood:	n/a	n/a
11	CBX3	chr5:178022105-178022545	K562	blood:	n/a	n/a
12	CBX3	chr5:178022153-178022422	K562	blood:	n/a	n/a
13	CBX3	chr5:178012432-178012781	K562	blood:	n/a	n/a
14	CBX3	chr5:178012426-178012835	K562	blood:	n/a	n/a
15	CCNT2	chr5:178016854-178017709	K562	blood:	n/a	n/a
16	CEBPB	chr5:178003384-178003412	H1-hESC	embryonic stem cell:	n/a	n/a
17	CEBPB	chr5:178010769-178011062	HepG2	liver:	n/a	chr5:178010920-178010931
18	CEBPB	chr5:178017703-178018021	K562	blood:	n/a	chr5:178017711-178017728
19	CEBPB	chr5:178010798-178011054	K562	blood:	n/a	chr5:178010920-178010931
20	CHD1	chr5:178012502-178012888	H1-hESC	embryonic stem cell:	n/a	n/a
21	CHD2	chr5:178012538-178012873	Hela-S3	cervix:	n/a	n/a
22	CHD2	chr5:178017245-178017402	H1-hESC	embryonic stem cell:	n/a	n/a
23	CHD2	chr5:178012512-178012880	K562	blood:	n/a	n/a
24	CHD2	chr5:178003820-178003977	H1-hESC	embryonic stem cell:	n/a	n/a
25	CTBP2	chr5:178003743-178004899	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTBP2	chr5:178017016-178017975	H1-hESC	embryonic stem cell:	n/a	n/a
27	CTCF	chr5:178017740-178017890	NHDF-neo	bronchial:	n/a	n/a
28	CTCF	chr5:178017280-178017430	HCPEpiC	choroid plexus:	n/a	n/a
29	CTCF	chr5:178017300-178017450	K562	blood:	n/a	n/a
30	CTCF	chr5:178017760-178017910	GM12873	blood:	n/a	n/a
31	CTCF	chr5:178012580-178012730	GM12872	blood:	n/a	n/a
32	CTCF	chr5:178016900-178017050	AG04449	skin:	n/a	n/a
33	CTCF	chr5:178017760-178017910	GM12871	blood:	n/a	n/a
34	CTCF	chr5:178016919-178017139	T-47D	breast:	n/a	n/a
35	CTCF	chr5:178017720-178017870	HEK293	kidney:	n/a	n/a
36	CTCF	chr5:178017760-178017910	HRE	kidney:	n/a	n/a
37	CTCF	chr5:178012560-178012710	AG10803	skin:	n/a	n/a
38	CTCF	chr5:178017720-178017870	HCM	heart:	n/a	n/a
39	CTCF	chr5:178017780-178017930	AG09309	skin:	n/a	n/a
40	CTCF	chr5:178017740-178017890	BE2_C	brain:	n/a	n/a
41	CTCF	chr5:178017760-178017910	HVMF	connective:	n/a	n/a
42	CTCF	chr5:178017695-178017943	SK-N-SH_RA	brain:	n/a	n/a
43	CTCF	chr5:178017336-178017439	Kidney_OC	kidney:	n/a	n/a
44	CTCF	chr5:178017123-178017126	H1-hESC	embryonic stem cell:	n/a	n/a
45	CTCF	chr5:178019122-178019166	GM12891	blood:	n/a	n/a
46	CTCF	chr5:178017689-178017971	SK-N-SH_RA	brain:	n/a	n/a
47	CTCF	chr5:178012560-178012710	HPAF	blood vessel:	n/a	n/a
48	CTCF	chr5:178017740-178017890	HA-sp	spinal cord:	n/a	n/a
49	CTCF	chr5:178017760-178017910	HCPEpiC	choroid plexus:	n/a	n/a
50	CTCF	chr5:178017757-178017949	GM13976	blood:	n/a	n/a

(count:1710 , 50 per page) page: 1 2 3 4 5 6 7 ... 35

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:178004685-178004735	NHBE	bronchial:	n/a
2	chr5:178003633-178003683	AG09309	skin:	n/a
3	chr5:178004685-178004735	NHBE	bronchial:	n/a
4	chr5:178003633-178003683	AG09309	skin:	n/a
5	chr5:178017853-178017903	Jurkat	blood:	n/a
6	chr5:178004204-178004254	NH-A	brain:	n/a
7	chr5:178017376-178017426	SK-N-SH	brain:	n/a
8	chr5:178016796-178016846	SKMC	muscle:	n/a
9	chr5:178021495-178021545	HCM	heart:	n/a
10	chr5:178007671-178007721	GM12891	blood:	n/a
11	chr5:178018186-178018236	GM06990	blood:	n/a
12	chr5:178004204-178004254	Caco-2	colon:	n/a
13	chr5:178017879-178017929	K562	blood:	n/a
14	chr5:178017669-178017719	HL-60	blood:	n/a
15	chr5:178017669-178017719	AG04449	skin:	fetal
16	chr5:178014801-178014851	HEEpiC	esophagus:	n/a
17	chr5:178017937-178017987	HNPCEpiC	eye:	n/a
18	chr5:178004091-178004141	NB4	blood:	n/a
19	chr5:178018186-178018236	GM19239	blood:	n/a
20	chr5:178017571-178017621	SK-N-SH	brain:	n/a
21	chr5:178018968-178019018	GM12878	blood:	n/a
22	chr5:178017667-178017717	SAEC	small airway:	n/a
23	chr5:178017571-178017621	ovcar-3	ovarian:	n/a
24	chr5:178017260-178017310	HRPEpiC	eye:	n/a
25	chr5:178017853-178017903	PrEC	prostate:	n/a
26	chr5:178016195-178016245	NT2-D1	testis:	n/a
27	chr5:178012716-178012766	HIPEpiC	eye:	n/a
28	chr5:178004091-178004141	BJ	skin:	n/a
29	chr5:178017667-178017717	AoSMC	blood vessel:	n/a
30	chr5:178017853-178017903	U87	brain:	n/a
31	chr5:178017879-178017929	AG09309	skin:	n/a
32	chr5:178004685-178004735	AG09309	skin:	n/a
33	chr5:178014589-178014639	HCPEpiC	choroid plexus:	n/a
34	chr5:178017376-178017426	Hepatocyte	liver:	n/a
35	chr5:178002446-178002496	HNPCEpiC	eye:	n/a
36	chr5:178018968-178019018	SK-N-SH_RA	brain:	n/a
37	chr5:178018968-178019018	HCPEpiC	choroid plexus:	n/a
38	chr5:178017376-178017426	HepG2	liver:	n/a
39	chr5:178017376-178017426	HCT-116	colon:	n/a
40	chr5:178017571-178017621	Caco-2	colon:	n/a
41	chr5:178007671-178007721	Jurkat	blood:	n/a
42	chr5:178002446-178002496	HL-60	blood:	n/a
43	chr5:178018186-178018236	AG09319	gingival:	n/a
44	chr5:178004012-178004062	AG04449	skin:	fetal
45	chr5:178021495-178021545	SK-N-MC	brain:	n/a
46	chr5:178021495-178021545	NHBE	bronchial:	n/a
47	chr5:178017571-178017621	CMK	blood:	n/a
48	chr5:178017376-178017426	Caco-2	colon:	n/a
49	chr5:178004091-178004141	Jurkat	blood:	n/a
50	chr5:178017376-178017426	H1-hESC	embryonic stem cell:	embryo

(count:16 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:178015408..178017355-chr5:178028126..178029814,2	MCF-7	breast:
2	chr5:178011858..178014216-chr5:178015047..178017974,2	MCF-7	breast:
3	chr5:177631253..177632828-chr5:178016105..178018488,2	MCF-7	breast:
4	chr5:177659189..177660088-chr5:178017540..178018315,2	K562	blood:
5	chr5:178006099..178008478-chr5:178010854..178012707,2	MCF-7	breast:
6	chr5:178024210..178026391-chr5:178026680..178028373,2	K562	blood:
7	chr5:178022246..178024591-chr5:178025333..178028233,2	MCF-7	breast:
8	chr5:178019997..178022007-chr5:178050984..178053956,2	MCF-7	breast:
9	chr5:178001407..178003756-chr5:178005377..178007780,2	K562	blood:
10	chr5:177997965..178000895-chr5:178002250..178003802,2	MCF-7	breast:
11	chr5:177995855..177997941-chr5:178001993..178004774,2	K562	blood:
12	chr5:177887805..177889193-chr5:178016576..178017370,3	MCF-7	breast:
13	chr5:178017942..178020045-chr5:178023632..178025333,2	K562	blood:
14	chr5:178017942..178020045-chr5:178023632..178025333,2	K562	blood:
15	chr5:178001407..178003756-chr5:178005377..178007780,2	K562	blood:
16	chr5:178006099..178008478-chr5:178010854..178012707,2	MCF-7	breast:

No data

Variant related genes	Relation type
COL23A1	TF binding region
COL23A1	CpG island
ENSG00000197451	chromatin interactions
ENSG00000175309	chromatin interactions
ENSG00000050767	chromatin interactions

Extended variants
information (count: 983 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:983 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs262055	chr5:178002325-178002326	Enhancers Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs262054	chr5:178002338-178002339	Enhancers Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs55943617	chr5:178002357-178002358	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs61140574	chr5:178002413-178002414	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs567519047	chr5:178002437-178002438	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs534829797	chr5:178002506-178002507	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs553177176	chr5:178002514-178002515	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs571445339	chr5:178002524-178002525	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs147540666	chr5:178002586-178002587	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs367874644	chr5:178002610-178002611	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs374657735	chr5:178002647-178002648	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs202072074	chr5:178002649-178002650	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs180871104	chr5:178002727-178002728	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs558225218	chr5:178002739-178002740	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs576408864	chr5:178002740-178002741	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs567416857	chr5:178002762-178002763	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs77147458	chr5:178002766-178002767	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs58757361	chr5:178002802-178002803	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs541245979	chr5:178002811-178002812	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs166375	chr5:178002822-178002823	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs262053	chr5:178002830-178002831	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs544816488	chr5:178002835-178002836	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs563392427	chr5:178002862-178002863	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs530426562	chr5:178002873-178002874	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs548966279	chr5:178002877-178002878	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs541291013	chr5:178002885-178002886	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs262052	chr5:178002901-178002902	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs78705096	chr5:178002912-178002913	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs117416126	chr5:178002971-178002972	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs115112473	chr5:178002975-178002976	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs35776611	chr5:178002989-178002990	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs547485	chr5:178002994-178002995	Enhancers Bivalent Enhancer Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs369907853	chr5:178003018-178003019	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs140067518	chr5:178003028-178003029	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs555311384	chr5:178003041-178003042	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs372404693	chr5:178003052-178003053	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs535015997	chr5:178003058-178003059	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs185499081	chr5:178003070-178003071	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs374772338	chr5:178003093-178003094	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs150043308	chr5:178003115-178003116	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs545536299	chr5:178003145-178003146	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs174440	chr5:178003165-178003166	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs563246540	chr5:178003200-178003201	Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs174439	chr5:178003217-178003218	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs190471877	chr5:178003226-178003227	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs369136956	chr5:178003261-178003262	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs510200	chr5:178003287-178003288	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs373418715	chr5:178003295-178003296	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs141413163	chr5:178003296-178003297	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs6893972	chr5:178003305-178003306	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Breast cancer	21990379	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:946 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:178000200-178003600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr5:178000600-178002600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr5:178000600-178003000	Strong transcription	Cortex derived primary cultured neurospheres	brain
4	chr5:178002200-178003000	Enhancers	ES-I3 Cell Line	embryonic stem cell
5	chr5:178002400-178003600	Bivalent Enhancer	Fetal Stomach	stomach
6	chr5:178002600-178002800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
7	chr5:178002600-178003200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr5:178002800-178003000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
9	chr5:178003000-178003200	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
10	chr5:178003000-178003200	Bivalent Enhancer	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
11	chr5:178003000-178003400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
12	chr5:178003000-178003400	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
13	chr5:178003000-178003600	Weak transcription	Cortex derived primary cultured neurospheres	brain
14	chr5:178003200-178003400	Enhancers	ES-I3 Cell Line	embryonic stem cell
15	chr5:178003200-178003400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
16	chr5:178003200-178003600	Bivalent Enhancer	Fetal Muscle Leg	muscle
17	chr5:178003200-178004000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
18	chr5:178003200-178005000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
19	chr5:178003400-178003600	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
20	chr5:178003400-178003600	Bivalent/Poised TSS	Monocytes-CD14+_RO01746	blood
21	chr5:178003400-178003800	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
22	chr5:178003400-178003800	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
23	chr5:178003400-178004000	Bivalent/Poised TSS	Fetal Brain Female	brain
24	chr5:178003400-178004000	Active TSS	Right Ventricle	heart
25	chr5:178003400-178004400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
26	chr5:178003400-178004400	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
27	chr5:178003400-178004800	Active TSS	ES-I3 Cell Line	embryonic stem cell
28	chr5:178003400-178004800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
29	chr5:178003400-178004800	Active TSS	iPS-15b Cell Line	embryonic stem cell
30	chr5:178003400-178004800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
31	chr5:178003400-178005000	Active TSS	H9 Cell Line	embryonic stem cell
32	chr5:178003400-178005000	Active TSS	HUES6 Cell Line	embryonic stem cell
33	chr5:178003400-178005000	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
34	chr5:178003600-178003800	Bivalent Enhancer	Primary hematopoietic stem cells	blood
35	chr5:178003600-178003800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
36	chr5:178003600-178003800	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
37	chr5:178003600-178003800	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
38	chr5:178003600-178003800	Bivalent Enhancer	Fetal Brain Male	brain
39	chr5:178003600-178003800	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
40	chr5:178003600-178003800	Bivalent Enhancer	Placenta	Placenta
41	chr5:178003600-178003800	Active TSS	Placenta Amnion	Placenta Amnion
42	chr5:178003600-178004000	Bivalent/Poised TSS	Breast Myoepithelial Primary Cells	Breast
43	chr5:178003600-178004200	Bivalent/Poised TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
44	chr5:178003600-178004200	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
45	chr5:178003600-178004200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
46	chr5:178003600-178004200	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
47	chr5:178003600-178004200	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
48	chr5:178003600-178004200	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
49	chr5:178003600-178004200	Active TSS	Brain Inferior Temporal Lobe	brain
50	chr5:178003600-178004200	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links